Author

B. Manavathi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Pan· 2 shared A. Swain· 2 shared B. Chatterjee· 2 shared C. G. Joshi· 2 shared J. Poyya· 2 shared K. Ghosh· 2 shared K. Nalla· 2 shared S. R. Kanade· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Pan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Ellagic acid: a potential inhibitor of enhancer of zeste homolog-2 and protein arginine methyltransferase-5

K. Nalla, B. Chatterjee, J. Poyya, A. Swain, K. Ghosh, A. Pan, C. G. Joshi, B. Manavathi, S. R. Kanade

This study identifies ellagic acid as an inhibitor of EZH2 and PRMT5:MEP50, showing reduced histone modifications and tumor growth in mouse models.

bioRxiv · May 22, 2024 · PreprintCancer Biology

Epigallocatechin-3-gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer both in vitro and in vivo

K. Nalla, B. Chatterjee, J. Poyya, A. Swain, K. Ghosh, A. Pan, C. G. Joshi, B. Manavathi, S. R. Kanade

This study shows that EGCG inhibits PRMT5 and EZH2 in breast cancer cells and xenografts, reducing histone repressive marks and inducing apoptosis and autophagy.

bioRxiv · Feb 18, 2024 · PreprintCancer Biology